6918 Stock Overview
Engages in the development of orthopedic trauma medical equipment products. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 1/6 |
Aplus Biotechnology Corporation Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$81.80 |
| 52 Week High | NT$96.90 |
| 52 Week Low | NT$43.85 |
| Beta | 0 |
| 11 Month Change | -4.66% |
| 3 Month Change | -4.55% |
| 1 Year Change | 79.98% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 63.60% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6918 | TW Medical Equipment | TW Market | |
|---|---|---|---|
| 7D | -3.7% | -0.5% | -0.8% |
| 1Y | 80.0% | 1.5% | 29.0% |
Return vs Industry: 6918 exceeded the TW Medical Equipment industry which returned 1.5% over the past year.
Return vs Market: 6918 exceeded the TW Market which returned 29% over the past year.
Price Volatility
| 6918 volatility | |
|---|---|
| 6918 Average Weekly Movement | 3.9% |
| Medical Equipment Industry Average Movement | 3.7% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in TW Market | 8.0% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 6918 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 6918's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | n/a | www.aplusbio.com |
Aplus Biotechnology Corporation Limited engages in the development of orthopedic trauma medical equipment products. The company is based in New Taipei City, Taiwan.
Aplus Biotechnology Corporation Limited Fundamentals Summary
| 6918 fundamental statistics | |
|---|---|
| Market cap | NT$2.49b |
| Earnings (TTM) | NT$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 6918 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6918 income statement (TTM) | |
|---|---|
| Revenue | NT$0 |
| Cost of Revenue | NT$0 |
| Gross Profit | NT$0 |
| Other Expenses | NT$0 |
| Earnings | NT$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 6918 perform over the long term?
See historical performance and comparison